Drugs / CAR
last change Dec 2022 re-read 3 minutes ago

CAR

Cell therapy

Developed for
nasopharyngeal carcinoma
Investigated by
Fudan University

Trials 1

20232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT05587543 Dec 2022 → Oct 2027 expected nasopharyngeal carcinoma Fudan University Recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CAR ClinicalTrials.gov intervention name — accepted as the source's own label NCT05587543 ↗
Modality Cell therapy “CAR-T cell therapy” NCT05587543 ↗